Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other financing activities (2018 - 2025)

CorMedix (CRMD) has disclosed Other financing activities for 7 consecutive years, with -$94377.0 as the latest value for Q4 2025.

  • Quarterly Other financing activities changed N/A to -$94377.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $188000.0 for FY2025, N/A changed from the prior year.
  • Other financing activities hit -$94377.0 in Q4 2025 for CorMedix, down from $49192.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.2 million in Q1 2023 to a low of -$94377.0 in Q4 2025.
  • Historically, Other financing activities has averaged $906733.3 across 3 years, with a median of $1.1 million in 2022.
  • Biggest YoY gain for Other financing activities was 94.71% in 2023; the steepest drop was 1.52% in 2023.
  • Year by year, Other financing activities stood at $1.1 million in 2022, then fell by 1.52% to $1.1 million in 2023, then crashed by 108.93% to -$94377.0 in 2025.
  • Business Quant data shows Other financing activities for CRMD at -$94377.0 in Q4 2025, $49192.0 in Q3 2025, and $1.1 million in Q2 2023.